Literature DB >> 23146898

Challenges in targeting cancer metabolism for cancer therapy.

Ryuji Yamaguchi1, Guy Perkins.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23146898      PMCID： PMC3512419          DOI： 10.1038/embor.2012.176

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  8 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

2.  Finding a Panacea among combination cancer therapies.

Authors:  Ryuji Yamaguchi; Guy Perkins
Journal:  Cancer Res       Date:  2011-11-03       Impact factor: 12.701

Review 3.  Exploring the genomes of cancer cells: progress and promise.

Authors:  Michael R Stratton
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

4.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

Authors:  Mariia O Yuneva; Teresa W M Fan; Thaddeus D Allen; Richard M Higashi; Dana V Ferraris; Takashi Tsukamoto; José M Matés; Francisco J Alonso; Chunmei Wang; Youngho Seo; Xin Chen; J Michael Bishop
Journal:  Cell Metab       Date:  2012-02-08       Impact factor: 27.287

5.  Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission.

Authors:  Heather A Hirsch; Dimitrios Iliopoulos; Philip N Tsichlis; Kevin Struhl
Journal:  Cancer Res       Date:  2009-09-14       Impact factor: 12.701

6.  Tumor growth need not be driven by rare cancer stem cells.

Authors:  Priscilla N Kelly; Aleksandar Dakic; Jerry M Adams; Stephen L Nutt; Andreas Strasser
Journal:  Science       Date:  2007-07-20       Impact factor: 47.728

7.  Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.

Authors:  Susana Ros; Claudio R Santos; Sofia Moco; Franziska Baenke; Gavin Kelly; Michael Howell; Nicola Zamboni; Almut Schulze
Journal:  Cancer Discov       Date:  2012-03-22       Impact factor: 39.397

8.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962
  8 in total
  5 in total

Review 1.  Connections between metabolism and epigenetics in cancers.

Authors:  Chitra Thakur; Fei Chen
Journal:  Semin Cancer Biol       Date:  2019-06-08       Impact factor: 15.707

2.  Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.

Authors:  Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Elisabet Cuyàs; Bruna Corominas-Faja; Esther Rodríguez-Gallego; Salvador Fernández-Arroyo; Begoña Martin-Castillo; Jorge Joven; Javier A Menendez
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

3.  Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients.

Authors:  Elisabet Cuyàs; Salvador Fernández-Arroyo; Maria Buxó; Sonia Pernas; Joan Dorca; Isabel Álvarez; Susana Martínez; Jose Manuel Pérez-Garcia; Norberto Batista-López; César A Rodríguez-Sánchez; Kepa Amillano; Severina Domínguez; Maria Luque; Idoia Morilla; Agostina Stradella; Gemma Viñas; Javier Cortés; Sara Verdura; Joan Brunet; Eugeni López-Bonet; Margarita Garcia; Samiha Saidani; Jorge Joven; Begoña Martin-Castillo; Javier A Menendez
Journal:  Aging (Albany NY)       Date:  2019-05-09       Impact factor: 5.682

4.  VHL-deficient renal cancer cells gain resistance to mitochondria-activating apoptosis inducers by activating AKT through the IGF1R-PI3K pathway.

Authors:  Ryuji Yamaguchi; Hiroshi Harada; Kiichi Hirota
Journal:  Tumour Biol       Date:  2016-07-26

Review 5.  Perspective on the dynamics of cancer.

Authors:  Youcef Derbal
Journal:  Theor Biol Med Model       Date:  2017-10-03       Impact factor: 2.432
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.